• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Eli Lilly

Eli Lilly

Eli Lilly and Co LLY 2 Star

Last Price$67.36Day Change (%)0.84%
Open Price$67.45Day Change ($)0.56
Day Range67.03–67.5052-Week Range48.88–68.67

As of Fri 11/21/2014 05:48 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Strong bull trend reaches latest technical test -2-

    Strong bull trend reaches latest technical test -2-

  2. Allied-Bristol Life Sciences Forms Strategic Partnership with Synergy Partners R&D Solutions to Advance Biopharmaceutical Innovations From Leading U.S. Academic Research Institutions

    Allied-Bristol Life Sciences Forms Strategic Partnership with Synergy Partners R&D Solutions to Advance Biopharmaceutical Innovations From Leading U.S. Academic Research Institutions

  3. Research and Markets: Global Biologic Therapeutics Market 2014-2018: Key Vendors are Amgen, F. Hoffmann-La Roche, Novo Nordisk and Sanofi

    Research and Markets: Global Biologic Therapeutics Market 2014-2018: Key Vendors are Amgen, F. Hoffmann-La Roche, Novo Nordisk and Sanofi

  4. Blood Clot and Heart Attack Risk after Coronary Stent Treatment Reduced with Continuation of Dual Antiplatelet Therapy beyond One Year in DAPT Study Findings

    Blood Clot and Heart Attack Risk after Coronary Stent Treatment Reduced with Continuation of Dual Antiplatelet Therapy beyond One Year in DAPT Study Findings

  5. UPDATE: Charting a strong bull trend with room -2-

    UPDATE: Charting a strong bull trend with room -2-

  6. UPDATE: Charting a strong bull trend with room -2-

    UPDATE: Charting a strong bull trend with room -2-

  7. Research and Markets: Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Pipeline Report 2014 - 32 Companies & 65 DRug Profiles

    Research and Markets: Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Pipeline Report 2014 - 32 Companies & 65 DRug Profiles

  8. Research and Markets: Bone Metastasis Therapeutics Pipeline Review, H2 2014 - 19 Companies & 31 Drug Profiles

    Research and Markets: Bone Metastasis Therapeutics Pipeline Review, H2 2014 - 19 Companies & 31 Drug Profiles

  9. Research and Markets: Metastatic Uveal Melanoma Therapeutics Pipeline Review, H2 2014 - 5 Companies & 7 Drug Profiles

    Research and Markets: Metastatic Uveal Melanoma Therapeutics Pipeline Review, H2 2014 - 5 Companies & 7 Drug Profiles

  10. Research and Markets: Global Bipolar Disorder (Manic Depression) Therapeutics Pipeline Review, H2 2014 - 22 Companies & 30 Drug Profiles

    Research and Markets: Global Bipolar Disorder (Manic Depression) Therapeutics Pipeline Review, H2 2014 - 22 Companies & 30 Drug Profiles

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.